🦵 ASA after THA/TKA: conflicting trials?
EPCAT III: ASA noninferior to 5-day rivaroxaban→ASA.
PEPPER: noninferiority vs 30-day anticoagulation unproven.
Different questions. Individualize prophylaxis. @NEJM
nejm.org/doi/full/10.10…
nejm.org/doi/full/10.10…
EPCAT III: ASA noninferior to 5-day rivaroxaban→ASA.
PEPPER: noninferiority vs 30-day anticoagulation unproven.
Different questions. Individualize prophylaxis. @NEJM
nejm.org/doi/full/10.10…
nejm.org/doi/full/10.10…